| pubmed-article:16402537 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16402537 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:16402537 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:16402537 | pubmed:dateCreated | 2006-1-11 | lld:pubmed |
| pubmed-article:16402537 | pubmed:abstractText | The topical treatment of psoriasis benefits from the alternate use of dermocorticosteroids and vitamin D3 analogues. A new galenic formulation allows to combine them in a single application. Dovobet (LEO Pharma) ointment is the association of calcipotriol 50 microg/g with betamethasone dipoprionate 0.5 mg/g. This formulation boosts the therapeutic activity of calcipotriol. It also decreases the irritative inflammatory reaction due to calcipotriol without increasing the atrophogenic risk of the dermocorticoid. | lld:pubmed |
| pubmed-article:16402537 | pubmed:language | fre | lld:pubmed |
| pubmed-article:16402537 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16402537 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16402537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16402537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16402537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16402537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16402537 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16402537 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16402537 | pubmed:issn | 0370-629X | lld:pubmed |
| pubmed-article:16402537 | pubmed:author | pubmed-author:DelvoyePP | lld:pubmed |
| pubmed-article:16402537 | pubmed:author | pubmed-author:PiérardG EGE | lld:pubmed |
| pubmed-article:16402537 | pubmed:author | pubmed-author:HenryFF | lld:pubmed |
| pubmed-article:16402537 | pubmed:author | pubmed-author:Piérard-Franc... | lld:pubmed |
| pubmed-article:16402537 | pubmed:author | pubmed-author:FlagothierCC | lld:pubmed |
| pubmed-article:16402537 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16402537 | pubmed:volume | 60 | lld:pubmed |
| pubmed-article:16402537 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16402537 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16402537 | pubmed:pagination | 893-5 | lld:pubmed |
| pubmed-article:16402537 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16402537 | pubmed:meshHeading | pubmed-meshheading:16402537... | lld:pubmed |
| pubmed-article:16402537 | pubmed:meshHeading | pubmed-meshheading:16402537... | lld:pubmed |
| pubmed-article:16402537 | pubmed:meshHeading | pubmed-meshheading:16402537... | lld:pubmed |
| pubmed-article:16402537 | pubmed:meshHeading | pubmed-meshheading:16402537... | lld:pubmed |
| pubmed-article:16402537 | pubmed:meshHeading | pubmed-meshheading:16402537... | lld:pubmed |
| pubmed-article:16402537 | pubmed:meshHeading | pubmed-meshheading:16402537... | lld:pubmed |
| pubmed-article:16402537 | pubmed:meshHeading | pubmed-meshheading:16402537... | lld:pubmed |
| pubmed-article:16402537 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16402537 | pubmed:articleTitle | [The calcipotriol-betamethasone dipropionate association]. | lld:pubmed |
| pubmed-article:16402537 | pubmed:affiliation | CHU du Sart Tilman, Service de Dermatopathologie, Liège. | lld:pubmed |
| pubmed-article:16402537 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16402537 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:16402537 | pubmed:publicationType | Review | lld:pubmed |
